Issue 35 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

35

September 30, 2005Sep 30, 2005

Free

DOWNLOAD THE PDF

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

Members of Congress say that won’t work.

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

After a “humble” start at NCI, von Eschenbach set unachievable goal.

Recent Issues

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026

Volume 52 | Issue 19 - May 15, 2026

Volume 52 | Issue 18 - May 08, 2026